{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-000307","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.428082+00:00","generated_at":"2026-06-20T09:28:39.007493+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Phio Pharma announces 1-for-12 reverse stock split to meet Nasdaq bid price requirement","bullets":["Board set ratio at 1-for-12; effective 12:01 a.m. ET Jan 26, 2023.","Outstanding shares reduced from ~13.7M to ~1.1M; no change to par value or voting rights.","Fractional shares paid in cash at $6.51/share based on 10-day average closing price.","Reverse split aimed at ensuring compliance with Nasdaq minimum $1.00 bid price requirement.","New CUSIP number 71880W402; trading symbol remains PHIO."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-000307","json":"https://secwatch.observer/filing/0001683168-23-000307.json","markdown":"https://secwatch.observer/filing/0001683168-23-000307.md","text":"https://secwatch.observer/filing/0001683168-23-000307.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000307/0001683168-23-000307-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000307/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:28:39.007493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6251fd3ed896c4859c281a29833e440fb4d30ea8","claim":"Phio Pharmaceuticals Corp.: Filed a Certificate of Amendment to effect a 1-for-12 reverse stock split of common stock (effective 2023-01-26).","evidence_excerpt":"thereafter, on January 24, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, to implement the 1-for-12 reverse split of its common stock (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316823000307/0001683168-23-000307-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-01-26"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}